Personal tools

Coexpression cluster:C3313: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C3313_Eosinophils_Basophils_CD14_Neutrophils_Peripheral_Whole_CD19 |id=C3313 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C3313_Eosinophils_Basophils_CD14_Neutrophils_Peripheral_Whole_CD19
|full_id=C3313_Eosinophils_Basophils_CD14_Neutrophils_Peripheral_Whole_CD19
|id=C3313
|id=C3313
|ontology_enrichment_celltype=CL:0000766!3.58e-35!76;CL:0002057!1.45e-34!42;CL:0000860!2.44e-33!45;CL:0000839!3.31e-29!70;CL:0000557!1.73e-28!71;CL:0000738!3.37e-28!140;CL:0002009!7.43e-27!65;CL:0002194!5.31e-26!63;CL:0000576!5.31e-26!63;CL:0000040!5.31e-26!63;CL:0000559!5.31e-26!63;CL:0002031!3.55e-23!124;CL:0000763!8.54e-23!112;CL:0000049!8.54e-23!112;CL:0000037!7.52e-22!172;CL:0000566!7.52e-22!172;CL:0000988!5.84e-21!182;CL:0002087!7.36e-21!119;CL:0002032!5.65e-20!165;CL:0000837!5.65e-20!165;CL:0002393!1.05e-08!9;CL:0002397!1.05e-08!9;CL:0000094!1.48e-08!8
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002390!5.27e-34!102;UBERON:0003061!5.27e-34!102;UBERON:0002193!1.15e-32!112;UBERON:0002371!8.09e-27!80;UBERON:0001474!1.10e-23!86;UBERON:0002405!3.33e-19!115;UBERON:0004765!5.20e-17!101;UBERON:0001434!5.20e-17!101;UBERON:0003081!1.40e-11!216;UBERON:0000178!4.22e-08!15;UBERON:0000179!4.22e-08!15;UBERON:0000463!4.22e-08!15;UBERON:0002204!7.27e-08!167
}}
}}

Revision as of 14:35, 21 May 2012


Full id: C3313_Eosinophils_Basophils_CD14_Neutrophils_Peripheral_Whole_CD19



Phase1 CAGE Peaks

Hg19::chr12:6250313..6250339,-p@chr12:6250313..6250339
-
Hg19::chr16:29168624..29168639,+p@chr16:29168624..29168639
+
Hg19::chr17:1532273..1532296,+p@chr17:1532273..1532296
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
myeloid leukocyte3.58e-3576
CD14-positive, CD16-negative classical monocyte1.45e-3442
classical monocyte2.44e-3345
myeloid lineage restricted progenitor cell3.31e-2970
granulocyte monocyte progenitor cell1.73e-2871
leukocyte3.37e-28140
macrophage dendritic cell progenitor7.43e-2765
monopoietic cell5.31e-2663
monocyte5.31e-2663
monoblast5.31e-2663
promonocyte5.31e-2663
hematopoietic lineage restricted progenitor cell3.55e-23124
myeloid cell8.54e-23112
common myeloid progenitor8.54e-23112
hematopoietic stem cell7.52e-22172
angioblastic mesenchymal cell7.52e-22172
hematopoietic cell5.84e-21182
nongranular leukocyte7.36e-21119
hematopoietic oligopotent progenitor cell5.65e-20165
hematopoietic multipotent progenitor cell5.65e-20165
intermediate monocyte1.05e-089
CD14-positive, CD16-positive monocyte1.05e-089
granulocyte1.48e-088
Uber Anatomy
Ontology termp-valuen
hematopoietic system5.27e-34102
blood island5.27e-34102
hemolymphoid system1.15e-32112
bone marrow8.09e-2780
bone element1.10e-2386
immune system3.33e-19115
skeletal element5.20e-17101
skeletal system5.20e-17101
lateral plate mesoderm1.40e-11216
blood4.22e-0815
haemolymphatic fluid4.22e-0815
organism substance4.22e-0815
musculoskeletal system7.27e-08167


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.